Ranbaxy gets NDA nod to market Flecainide acetate
Ranbaxy Laboratories Limited (RLL) has received approval from the US Food and Drug Administration (USFDA) to market Flecainide Acetate tablets USP therapeutically equivalent to the listed drug
Ranbaxy Laboratories Limited (RLL) has received approval from the US Food and Drug Administration (USFDA) to market Flecainide Acetate tablets USP therapeutically equivalent to the listed drug